Biden-Harris Administration Finalizes Rule Expanding Access to …
2024年4月4日 — Additionally, the rule finalizes new guardrails for certain types of supplemental benefits, available only to chronically ill enrollees, to ensure that these supplemental benefits offered by a Medicare Advantage plan meet the health needs of people with Medicare by being supported by evidence.
HHS Announces Cost Savings for 54 Prescription Drugs Thanks to …
2024年9月30日 — The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), today announced that some Medicare enrollees will pay less for 54 drugs available through Medicare Part B.
Biden-Harris Administration Strengthens Medicare with Finalized ...
2022年10月28日 — Today, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that updates Medicare enrollment and eligibility rules to expand coverage for people with Medicare and advance health equity.
Biden-Harris Administration is Strengthening Medicare; Protecting …
2024年1月31日 — Medicare Advantage is robust and stable, and plan offerings and enrollment are strong for beneficiaries in 2024, including premiums, supplemental benefits, and choice. The Medicare Advantage average monthly plan premium remains stable in 2024, with an increase of less than one dollar on average.
HHS Releases Final Guidance for Second Cycle of Historic …
2024年10月2日 — As part of the continued implementation of the Biden-Harris Administration’s historic prescription drug law, the Inflation Reduction Act, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), released final guidance today outlining the process for the second cycle of negotiations ...
Biden-Harris Administration Takes Next Step on Proposed Model …
2024年10月9日 — “The Medicare $2 Drug List Model will aim to help improve access to and affordability of low-cost generic drugs for people with Medicare prescription drug coverage, and we encourage the public to provide feedback on the model.”
HHS Announces Actions to Lower Health Care Costs and Allow …
2023年6月30日 — HHS released revised drug price negotiation guidance from the Centers for Medicare & Medicaid Services (CMS). The guidance is a critical step in implementing the IRA, which finally took on Big Pharma and will allow Medicare to negotiate lower drug prices on behalf of people with Medicare.
CMS Issues Draft Guidance on New Program to Allow People with …
2023年8月21日 — President Biden’s prescription drug law, the Inflation Reduction Act, gives people with Medicare prescription drug coverage (Medicare Part D) the option to pay out-of-pocket costs in monthly payments spread out over the year, starting in 2025.
HHS Announces Cost Savings for 64 Prescription Drugs Thanks to …
2024年6月26日 — The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), today announced that some Medicare enrollees will pay less for 64 drugs available through Medicare Part B.
HHS Finalizes Rule to Strengthen Medicare, Improve Access to …
2023年4月5日 — Today, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), is finalizing a rule to put people with Medicare first and put strong protections in place so that Medicare Advantage (MA) works for them.